How Effective is Botox in Improving UE Function?

Muscle spasticity is a negative symptom which can occur following a central nervous system disorder (Kinnear, 2012). The use of Botulinum Toxin Type A (BTX-A), commonly referred to as Botox, is used extensively in the treatment of muscle spasticity following stroke and other neurological conditions. Following BTX-A injections, physical and occupational therapy are typically provided and include stretching, casting, splinting, strengthening, and functional movement retraining (Kinnear, 2012). Having provided the above types of occupational therapy interventions with numerous individuals who have received Botox injections to the UE, I have formulated my own opinions as to the functional benefits of Botox injections in the...

Good News; Healthcare Reform and Changes in Medicare

As clinicians, our ability to provide therapy services to clients is influenced by federal laws and regulations, administrative laws from agencies, and sometimes case law. It becomes challenging to keep track of all the changes that occur in the laws, rules, and regulations that impact our practice. More often, we are aware of changes that negatively impact our ability to provide comprehensive and medically necessary skilled services to achieve optimum client outcomes, such as therapy caps. We are also aware of changes in regulations that impact what we document and the way we document. As discussed in the prior blog, clinicians...

“Saebo products are my favorite tool when working with patients who have had a stroke”

I love that Saebo products use the principles of neuroplasticity to provide concrete mass practice exercises that increase patient compliance with an affected extremity. The SaeboMAS is the product I have used the most. The MAS supports the weight of an affected arm and allows the patient to use volitional movement for NMR. That way, the therapist does not have to provide support for the arm or follow the patient while they are relearning movement; instead, the MAS allows the patient to gain independence and perform movements on their own. I love that the SaeboMAS is essentially another set of hands...

Is What You’re Doing Working? How Do You Know?

As many of you are already aware, those billing to Medicare for therapy coverage now have to report functional outcome data for clients in the form of new non-payable G codes. The G codes are designed to capture the primary issue for which therapy is being provided for. This includes issues such as mobility, changing/maintaining body position, carrying/moving/handling objects, and self-care to name a few. G codes are accompanied by modifiers which indicate the client’s area of limitation and are designed to help track functional changes over time which subsequently results in payment information. These codes are required to not...

April is OT Month! Saebo Supports the AOTA Centennial Vision.

The AOTA Centennial Vision In celebration of April being OT month, it seems appropriate to discuss AOTA’s Centennial Vision (CV) for the profession. Many will already be familiar with the CV, but there are many that likely are not. In 2006, The American Occupational Therapy Association established the Centennial Vision as a “strategic plan” (AOTA, 2006, p.1) for the profession as it approaches its 100th anniversary in 2017. It was established to provide strategies for occupational therapists at all levels of service, to enable the profession to remain “viable and contemporary” (Baum, 2006, p. 610) in light of changes in society, health care,...